Read the latest news and updates from NCATS.

Is this email not displaying correctly?
View it in your browser.

National Center for Advancing Translational Sciences | Catalyzing Innovation
Volume 05 • Issue 03 • March 24, 2016

Director's Message

NCATS Director Dr. Austin

Last month, in anticipation of Rare Disease Day at NIH, I wrote about the importance of rare diseases research and NCATS’ multifaceted approach to tackling these conditions. I’m delighted to report that the NIH event was a standing-room-only, record-breaking success and...


Connect with NCATS


Top Story

Mother diagnosed with LAM

Breathing Easier: First Treatment for Rare Lung Disease Approved

Lymphangioleiomyomatosis (LAM) is a progressive rare lung disease that mostly affects women of child-bearing age. Seamless collaboration among advocates from The LAM Foundation and scientists in NCATS’ Rare Diseases Clinical Research Network enabled a multicenter international clinical trial that led to the first LAM treatment approved by the Food and Drug Administration. Read more >

Facebook logo
Twitter logo

Recursion Pharmaceuticals

Small Business Award Helps Launch Drug Discovery Platform

NCATS’ small business support helped scientist and entrepreneur Christopher Gibson, Ph.D., launch a rapidly growing drug discovery company that has, in its first year, attracted more than $3.5 million in private investments. Read more >

Twitter logo

Assay Guidance Manual

NCATS & FDA Offer April Assay Guidance Event

Are you a scientist involved in assay development for high-throughput screening and lead optimization? Join NCATS and Food and Drug Administration researchers for a workshop April 5-6, 2016, in College Park, Maryland. Drug discovery experts will share advice, best practices, and a broad range of critical concepts and underlying assay development and lead strategies. Read more >

Facebook logo
Twitter logo

2016 Rare Disease Day at NIH

Rare Disease Day at NIH: Making a Difference

Hundreds of patients, advocates, caregivers and researchers participated in Rare Disease Day at NIH on Feb. 29, 2016. Hosted by NCATS and the NIH Clinical Center, the event featured powerful presentations, remarks by congressional and NIH leadership, posters and exhibits, tours of the Clinical Center, and more. View photos >

Twitter logo

Portraits of Drs. Balakrishnan and Hall

Meet More NCATS Staff

Krishna Balakrishnan, Ph.D., M.B.A., is the senior technology transfer manager in the NCATS Office of Strategic Alliances. Matthew D. Hall, Ph.D., is the biology group leader of the NCATS Chemical Genomics Center within the Division of Pre-Clinical Innovation. Learn more about these and other NCATS staff members via NCATS Staff Profiles >

Twitter logo



Small business owners: Don’t miss the next SBIR/STTR Omnibus Solicitation application deadline!


NCATS will host Pfizer’s Centers for Therapeutic Innovation workshop for NIH intramural researchers.

Research Opportunities and Announcements Highlights

More From NCATS

NCATS in the News

like us on Facebook |  follow us on Twitter |  forward to a friend |  watch us on YouTube

National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892

For language access assistance, contact the NCATS Public Information Officer.

Add us to your address book | Unsubscribe
NIH, National Center for Advancing Translational Sciences